Cargando…

A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma

Dysregulation of autophagy-related genes (ARGs) is related to the prognosis of cancers. However, the aberrant expression of ARGs signature in the prognosis of hepatocellular carcinoma (HCC) remain unclear. Using The Cancer Genome Atlas and the International Cancer Genome Consortium database, 188 com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, ZeBing, Zhang, GuoPei, Yu, Yang, Li, ShaoQiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419440/ https://www.ncbi.nlm.nih.gov/pubmed/34497633 http://dx.doi.org/10.3389/fgene.2021.689801

Ejemplares similares

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
por: Zhou, Xianghong, et al.
Publicado: (2020)

Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication
por: Jiang, Nan, et al.
Publicado: (2021)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
por: Ren, Huili, et al.
Publicado: (2022)

Machine Learning Screens Potential Drugs Targeting a Prognostic Gene Signature Associated With Proliferation in Hepatocellular Carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
por: Wang, Dongjiao, et al.
Publicado: (2022)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma
por: Jia, Yu, et al.
Publicado: (2020)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
por: Zhou, Zhiyang, et al.
Publicado: (2022)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer
por: Li, Na, et al.
Publicado: (2020)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
por: Zhao, Chunxia, et al.
Publicado: (2021)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021)

A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022)

Corrigendum: A novel ferroptosis-related LncRNA pair prognostic signature predicts immune landscapes and treatment responses for gastric cancer patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Prediction of small molecule drug-miRNA associations based on GNNs and CNNs
por: Niu, Zheyu, et al.
Publicado: (2023)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

The Construction of a Prognostic Model Based on a Peptidyl Prolyl Cis–Trans Isomerase Gene Signature in Hepatocellular Carcinoma
por: Shi, Huadi, et al.
Publicado: (2021)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes
por: Sun, Ruge, et al.
Publicado: (2022)

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
por: Ren, Ziyuan, et al.
Publicado: (2021)

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance
por: Tong, Xiaoxia, et al.
Publicado: (2022)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6902ks3cukle6ovqg68t3dei7d